Pharmacology of 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470), a novel, short-acting adenosine A2A receptor agonist that produces selective coronary vasodilation

This publication has 16 references indexed in Scilit:

• Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registry
  Published by Elsevier ,2010
• Myocardial Contrast Echocardiography in Acute Myocardial Infarction Using Aortic Root Injections of Microbubbles in Conjunction With Harmonic Imaging: Potential Application in the Cardiac Catheterization Laboratory
  Journal of the American College of Cardiology, 1997
• Pharmacological Stress Thallium Scintigraphy With 2-Cyclohexylmethylidenehydrazinoadenosine (WRC-0470)
  Circulation, 1996
• Selective Attenuation by N-0861 ( N ⁶ -Endonorboran-2-yl-9-Methyladenine) of Cardiac A ₁ Adenosine Receptor–Mediated Effects in Humans
  Circulation, 1996
• Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.
  Journal of Clinical Investigation, 1995
• Hemodynamic Responses and Adverse Effects Associated With Adenosine and Dipyridamole Pharmacologic Stress Testing: A Comparison in 2,000 Patients
  Mayo Clinic Proceedings, 1995
• Adenosine-induced bronchoconstriction and its inhibition by nedocromil sodium
  Journal of Allergy and Clinical Immunology, 1993
• Adenosine system in the heart
  Drug Development Research, 1993
• Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease
  Journal of the American College of Cardiology, 1991
• Dipyridamole thallium 201 imaging. How safe is it?
  Circulation, 1990